FDA PMA
FDA Class 3
Approved
🇺🇸 United States
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
PMA: P230043
·
Supplement: S001
·
Decision Jul 18, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0
Basic Information
- Device Name
- System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
- Trade Name
- Cologuard Plus
- PMA Number
- P230043
- Supplement Number
- S001
- Device Class
- FDA Class 3
- Product Code
- PHP
- Generic Name
- System, colorectal neoplasia, DNA methylation and hemoglobin detection
- Medical Specialty
- Unknown
- Advisory Committee
- Pathology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- July 18, 2025
- Date Received
- April 25, 2025
- Supplement Type
- Real-Time Process
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
Approval of a labeling change affecting two PMAs Cologuard (P130017) and Cologuard Plus (P230043), to introduce a new "Dual Labeled Cologuard Collection Kit" that can be used with both Cologuard (P130017) and Cologuard Plus (P230043).
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PHP | System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection | FDA class 3 | Unknown |